11/12/2019
As there may be adverse effects associated with excessive dosing, the dosage or frequency of administration should only be increased on medical advice.
Tablet: Adults: Usual Effective Dose: 4 mg 3 or 4 times/day. If adequate bronchodilatation is not obtained, each single dose may be gradually increased to as much as 8 mg. However, it has been established that some patients obtain adequate relief with 2 mg 3 or 4 times daily.
Children >12 years: 2-4 mg; 6-12 years: 1 tab (2 mg); 2-6 years: ½-1 tab (1-2 mg). To be administered 3 or 4 times daily.
Salda is well tolerated by children so that, if necessary, these doses can be cautiously increased.
Elderly or Patients known to be Unusually Sensitive to β-Adrenergic Stimulant Drugs: It is advisable to initiate treatment with 2 mg 3 or 4 times/day.
In the management of premature labour, after uterine contractions have been controlled by IV infusion of Salda and the infusion has been withdrawn, maintenance therapy can be continued with oral Salda. The usual dosage is 4 mg 3 or 4 times daily.
Syrup: Adults: 10 mL 3 or 4 times a day. Children: >12 years: 5-10 mL; 6-12 years: 5 mL; 2-6 years: 2.5-5 mL. To be taken 3 or 4 times a day.
Dilution: Salda syrup does not contain sugars. It may be diluted with purified water. The resulting mixture should be protected from light and used within 28 days. A 50% v/v dilution of Salda syrup has been shown to be adequately preserved against microbial contamination. However, to avoid the possibility of introducing excessive microbial contamination, the purified water used for dilution should be recently prepared or alternatively, it should be boiled and cooled immediately before use. Dilution of Salda syrup with syrup or sorbitol solution is not recommended as this may result in precipitation of the cellulose-thickening agent. Admixture of Salda syrup with other liquid preparations is not recommended.
Inhalation Solution: Intermittent Administration: Adults: 0.5-1 mL (2.5-5 mg of Salda) should be diluted to a final volume of 2 or 2.5 mL with normal saline for injection. The resulting solution is inhaled from a suitably driven nebuliser until aerosol generation ceases. Using a correctly matched nebuliser and driving source, this should take about 10 min.
Salda respirator solution may be used undiluted for intermittent administration. For this, 2 mL of Salda respirator solution (10 mg Salda) is placed in the nebuliser and the patient allowed to inhale the nebulised solution until bronchodilatation is achieved. This usually takes 3-5 min.
Some adult patients may require higher doses of Salda, up to 10 mg, in which case nebulisation of the undiluted solution may continue until aerosol generation ceases.
Children: The same mode of administration for intermittent administration is also applicable to children.
Usual Dose: Children
News News DailyMed Announcements Posted: November 27, 2019 NLM Flagging SPLs Associated With Inactivated NDCs In October 2019, NLM added an Indexing File (FDA-INITIATED COMPLIANCE ACTION - DRUG LISTING INACTIVATION) that includes NDCs from outdated or uncertified FDA listing records. NLM is now flag...
